Contribution of adenosine A2B receptors in clostridium difficile intoxication and infection

Infection and Immunity

Volumn 80, Issue 12, 2012, Pages 4463-4473

  Warren, Cirle A ^a   Li, Yuesheng ^a   Calabrese Gina M , G M ^a   Freire, Rosemayre S ^b   Zaja Milatovic, Snjezana ^a   Opstal, Edward van ^a   Figler, Robert A ^c   Linden, Joel ^d   Guerrant, Richard L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c HemoShear LLC   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ATL 692; ATL 801; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; INTERLEUKIN 6; MESSENGER RNA; PSB 1115; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; CELL LINE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DRUG EFFICACY; ENTERITIS; FEMALE; GENE DELETION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IC 50; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; MALE; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RABBIT; RECEPTOR UPREGULATION; TREATMENT OUTCOME; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL LINE, TUMOR; CLOSTRIDIUM DIFFICILE; COLON; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; GENE EXPRESSION REGULATION; HUMANS; ILEUM; MICE; MICE, INBRED C57BL; RABBITS; RECEPTOR, ADENOSINE A2B;

EID: 84870852500     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00782-12     Document Type: Article

References (41)

1. Alcantara C, Stenson WF, Steiner TS, Guerrant RL. 2001. Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model. J. Infect. Dis. 184:648-652.
2. Alcantara CS, et al. 2005. Angiotensin II subtype 1 receptor blockade inhibits Clostridium difficile toxin A-induced intestinal secretion in a rabbit model. J. Infect. Dis. 191:2090-2096.
3. Auchampach JA, et al. 2009. Characterization of the A2B adenosine receptor from mouse, rabbit, and dog. J. Pharmacol. Exp. Ther. 329:2-13.
4. Barrett KE, Cohn JA, Huott PA, Wasserman SI, Dharmsathaphorn K. 1990. Immune-related intestinal chloride secretion. II. Effect of adenosine on T84 cell line. Am. J. Physiol. 258:C902-C912.
5. Brito GA, et al. 2002. Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells. J. Infect. Dis. 186:1438-1447.
6. Britton RA, Young VB. 2012. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 20:313-319.
7. Carneiro BA, et al. 2006. Caspase and Bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro. Infect. Immun. 74: 81-87.
8. Cavalcante IC, et al. 2006. Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis. Infect. Immun. 74:2606-2612.
9. Chen X, et al. 2008. A mouse model of Clostridium difficile-associated disease. Gastroenterology 135:1984-1992.
10. Cheng Y, Prusoff WH. 1973. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108.
11. D'Auria KM, et al. 2012. Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control. BMC Syst. Biol. 6:2. doi:10.1186/1752-0509-6-2.
12. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:527-552.
13. Frick JS, et al. 2009. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J. Immunol. 182:4957-4964.
14. Gerhard R, et al. 2008. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. J. Med. Microbiol. 57:765-770.
15. Greger R. 2000. Role of CFTR in the colon. Annu. Rev. Physiol. 62:467-491.
16. Hart ML, et al. 2011. Hypoxia-inducible factor-1alpha-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'- nucleotidase (CD73) and the A2B adenosine receptor. J. Immunol. 186: 4367-4374.
17. Hart ML, Jacobi B, Schittenhelm J, Henn M, Eltzschig HK. 2009. Cutting edge: A2B adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J. Immunol. 182:3965-3968.
18. Hasko G, Pacher P. 2008. A2A receptors in inflammation and injury: lessons learned from transgenic animals. J. Leukoc. Biol. 83:447-455.
19. He D, et al. 2002. Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. Gastroenterology 122:1048-1057.
20. Just I, et al. 1994. Clostridium difficile toxin B acts on the GTP-binding protein Rho. J. Biol. Chem. 269:10706-10712.
21. Just I, Selzer J, von Eichel-Streiber C, Aktories K. 1995. The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. J. Clin. Invest. 95:1026-1031.
22. Kelly CP, Lamont JT. 2008. Clostridium difficile-more difficult than ever. N. Engl. J. Med. 359:1932-1940.
23. Kolachala V, et al. 2005. TNF-alpha upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells: a basis for A2bR overexpression in colitis. Cell. Mol. Life Sci. 62:2647-2657.
24. Kolachala VL, et al. 2008. Blockade of adenosine A(2B) receptors ameliorates murine colitis. Br. J. Pharmacol. 155:127-137.
25. Kolachala VL, et al. 2008. A2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology 135:861-870.
26. Libby DB, Bearman G. 2009. Bacteremia due to Clostridium difficile- review of the literature. Int. J. Infect. Dis. 13:e305- e309.
27. Lima AA, Lyerly DM, Wilkins TD, Innes DJ, Guerrant RL. 1988. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect. Immun. 56:582-588.
28. Lima AA, et al. 2008. Role of phospholipase A2 and tyrosine kinase in Clostridium difficile toxin A-induced disruption of epithelial integrity, histologic inflammatory damage and intestinal secretion. J. Appl. Toxicol. 28:849-857.
29. Mahida YR, Makh S, Hyde S, Gray T, Borriello SP. 1996. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 38:337-347.
30. Moore R, Pothoulakis C, Lamont JT, Carlson S, Madara JL. 1990. C. difficile toxinAincreases intestinal permeability and induces Cl-secretion. Am. J. Physiol. 259:G165-G172.
31. Pawlowski SW, et al. 2010. Murine model of Clostridium difficile infection using gnotobiotic aged C57Bl/6 mice and a BI strain. J. Infect. Dis. 202: 1708-1712.
32. Pothoulakis C, Lamont JT. 2001. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. II. The integrated response of the intestine to Clostridium difficile toxins. Am. J. Physiol. Gastrointest. Liver Physiol. 280:G178-G183.
33. Sitaraman SV, et al. 2001. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J. Clin. Invest. 107:861-869.
34. Stehle JH, et al. 1992. Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol. Endocrinol. 6:384-393.
35. Strohmeier GR, et al. 1997. Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J. Clin. Invest. 99:2588-2601.
36. Strohmeier GR, Reppert SM, Lencer WI, Madara JL. 1995. The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J. Biol. Chem. 270:2387-2394.
37. Sullivan GW, Linden J, Buster BL, Scheld WM. 1999. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J. Infect. Dis. 180:1550-1560.
38. Triadafilopoulos G, Pothoulakis C, O'Brien MJ, Lamont JT. 1987. Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology 93:273-279.
39. Voth DE, Ballard JD. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-263.
40. Warny M, et al. 2000. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J. Clin. Invest. 105:1147-1156.
41. Warren CA, et al. 2012. Effects of adenosine A(2)A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice. BMC Infect. Dis. 12:13. doi:10.1186/1471-2334-12-13.